BASF India Limited share price
NSE: BASF · ISIN INE373A01013
Key numbers
- Market cap
- ₹ 15,322 Cr
- Current price
- ₹ 3,539.80
- 52-week high / low
- ₹ 4,830 / 3,122
- Stock P/E
- 24.8
- Book value
- ₹ 914.3
- Dividend yield
- 0.71%
- ROCE
- 14.7%
- ROE
- 11.1%
- Debt to equity
- 0.03
- Sales growth (3 yrs)
- 3.1%
- Profit growth (3 yrs)
- 1.4%
- 1-year return
- -23.2%
About BASF India Limited
BASF India Limited provides chemicals, materials, industrial solutions, nutrition and care, and agricultural solutions in India and internationally. The company's Agricultural Solution segment offers crop protection products, such as insecticides, herbicides, fungicides, and plant growth regulators, as well as seed treatment solutions. Its Materials segment offers performance materials, such as polyurethane, and engineering and specialty plastics; and monomers comprising basic raw materials for polyurethanes, inorganics, and polyamides, as well as its precursors. The company's Industrial Solutions segment provides dispersions, resins, additives, and performance chemicals for paints and coatings, construction, paper, adhesives, automobiles, printing, and packaging industries. Its Nutrition & Care segment provides solutions for personal care, home care and institutional cleaning, and industrial formulation for textile, leather, agrochemicals, and metal surface cleaning; and products for human and animal nutrition, pharma solutions, and aroma ingredients. The company's Chemicals segment provides petrochemicals, including oxo-alcohols, acrylic acid, acrylic monomers, superabsorbent,…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 3,740 | 4,042 | 3,859 | 3,439 | 4,820 |
| Operating profit | 223 | 166 | 170 | 111 | 504 |
| Net profit | 137 | 107 | 107 | 69 | 360 |
| EPS (₹) | 31.70 | 24.80 | 24.60 | 16.00 | 83.30 |
Investor presentation summary (2026-08-12)
AI summary of the presentation · tone: Positive · source document
Key numbers
- [Apr to Jun 26 (Revenue : 174 , PBTbEI : 19 (Incl. gain of Rs. 18 Crs on sale of 100% equity shares of WOS) | Apr to Jun 25 (Revenue : 133 , PBTbEI : -12)]
Guidance & outlook
- We will not provide any forecast or outlook regarding future
- NCLT* approval expected by end of 2026 .
Growth & demand
- Revenue: Higher volumes, but lower price realisation
- Revenue and PBT bEI improved from higher volumes and better price realisation
Margins & costs
- PBTbEI : Impacted due to higher input cost and product mix
Capex & expansion
- capacity enhancement at Dahej
- and wind power for plants in Gujarat and Maharashtra
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.